Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Armitage James O Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2022 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 13,000 shares @ $1.5564, valued at $20.2k
03/10/2022 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 26,800 options @ $2.5, valued at $67k
06/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2020 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Granted 28,858 options @ $2.6, valued at $75k
05/18/2020 4 Armitage James O (Director) has filed a Form 4 on Cardiff Oncology, Inc.
Txns: Bought 10,490 shares @ $1.43, valued at $15k
05/01/2020 4 Armitage James O (Director) has filed a Form 4 on Trovagene, Inc.
Txns: Granted 11,916 options @ $0.98, valued at $11.7k
01/22/2019 4 Armitage James O (Director) has filed a Form 4 on TESARO, Inc.
Txns: Unknown transaction of 1,500 shares @ $75, valued at $112.5k
Disposed/sold 4,052 restricted stock units @ $0
Disposed/sold 25,000 options to buy @ $46.22, valued at $1.2M
Disposed/sold 10,000 options to buy @ $60.77, valued at $607.7k
Disposed/sold 12,000 options to buy @ $47.27, valued at $567.2k
Disposed/sold 12,000 options to buy @ $149.22, valued at $1.8M
Disposed/sold 7,209 options to buy @ $46.89, valued at $338k
06/05/2018 4 Armitage James O (Director) has filed a Form 4 on TESARO, Inc.
Txns: Granted 7,209 options to buy @ $46.89, valued at $338k
Granted 4,052 restricted stock units @ $0
09/20/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/05/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy